ICON (ICLR)
(Delayed Data from NSDQ)
$301.61 USD
+3.73 (1.25%)
Updated May 1, 2024 04:00 PM ET
After-Market: $301.62 +0.01 (0.00%) 6:42 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$301.61 USD
+3.73 (1.25%)
Updated May 1, 2024 04:00 PM ET
After-Market: $301.62 +0.01 (0.00%) 6:42 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Zacks News
Here is Why Growth Investors Should Buy Icon PLC (ICLR) Now
by Zacks Equity Research
Icon PLC (ICLR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Icon PLC (ICLR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amedisys (AMED) Latest New York Assets Buyout Aids Home Health
by Zacks Equity Research
The latest development remains in line with Amedisys' (AMED) ongoing efforts to expand footprint in key markets.
Charles River (CRL) at a 52-Week High: What's Driving It?
by Zacks Equity Research
Strong performance by the RMS, DSA and Manufacturing segments is driving the top line for Charles River (CRL).
LHC Group (LHCG) & SCP Health to Offer Home Health Services
by Zacks Equity Research
LHC Group (LHCG) collaborates with SCP Health to provide innovative and advanced in-home healthcare services.
New Strong Buy Stocks for July 8th
by Zacks Equity Research
MTZ, OLN, CVA, ICLR, and NX have been added to the Zacks Rank #1 (Strong Buy) List on July 8, 2021.
Avantor, Inc. (AVTR) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Avantor, Inc. (AVTR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Icon PLC (ICLR) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Icon PLC (ICLR) could produce exceptional returns because of its solid growth attributes.
Icon PLC (ICLR) Soars 4.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Icon PLC (ICLR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Icon PLC (ICLR) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 6.74% and 9.96%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
MedTech M&A Scaling New Heights in 2021 on Rising Investor Wealth
by Urmimala Biswas
While smaller tuck-in acquisitions dominated the M&A space throughout 2020, 2021 is seeing a number of colossal deals.
Icon PLC (ICLR) Soars 4.5%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Icon PLC (ICLR) Surges 4.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Icon PLC (ICLR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
Icon PLC (ICLR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 3.83% and 1.57%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Icon PLC (ICLR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will Icon PLC (ICLR) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Icon PLC (ICLR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Icon PLC (ICLR) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 10.97% and 5.54%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 9.09% and 4.36%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Icon PLC (ICLR) Q2 Earnings Expected to Decline
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Icon PLC (ICLR) Q1 Earnings Lag Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of -1.16% and 0.01%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON
by Zacks Equity Research
Zacks.com featured highlights include: Design System, The Toro Company, Charles River Laboratories International and ICON
4 GARP Stocks for a Winning Portfolio
by Zacks Equity Research
Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
Icon PLC (ICLR) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Icon PLC (ICLR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Icon PLC (ICLR) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Icon PLC (ICLR) delivered earnings and revenue surprises of 0.58% and 0.32%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Icon PLC (ICLR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Icon PLC (ICLR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.